Elucidating the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis

J Clin Endocrinol Metab. 2025 Mar 24:dgaf165. doi: 10.1210/clinem/dgaf165. Online ahead of print.

Authors

Bibi Uhre Nielsen¹, James A M Shaw²

Affiliations

¹ Cystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
² Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

PMID: 40126533
DOI: 10.1210/clinem/dgaf165

No abstract available

Keywords: cystic fibrosis; cystic fibrosis-related diabetes; elexacaftor/tezacaftor/ivacaftor; insulin secretion; insulin sensitivity.

Publication types

Editorial
Comment